Stem cells are a class of multi-cellular organisms, which act as the foundation for every organ and tissue in the body and are developed in different types of cells. Stem cells work as an internal repair system in the body, helping fight chronic diseases. The increasing cases of chronic diseases all around the world is the key trend for the global stem cell assay market. The global stem cell assay market is expected to have a CAGR of 21.5% during the forecast period 2016 to 2023. Rising investment in research, increase in funds for stem cell research, technological advancements are some of the factors contributing to the growth of global stem cell assay market. However, high cost of stem cell based therapies is the key restraining factor for the growth of this market.
According to World Health Organization, 8.8 million people died of cancer in 2015. According to Partnership to Fight Chronic Disease Organization, in 2015, 191 million people suffered from chronic disease in America and more than 75 million suffered from two or more chronic diseases. As stem cells are widely used for the treatment of specific cancers which has led to the growth of global stem cell assay market.
Source: OBRC Analysis.
The report on global stem cell assay market segmentation includes technology, assay type, kits, product and end-user.
Technology is sub-segmented into:
- Micro fabricated assisted technology
- Micro fluidics based cell trap technologies
- Technology in development
Assay is further segmented into:
- Cell viability & toxicity assays
- Isolation/Purification assays
- Cell identification assays
- Cell proliferation assays
- Cell differentiation assays
- Cell function assays
- Cell apoptosis assays
Kits are further segmented into:
- Adult stem cell kits
- Human embryonic stem cells kits
Product is further segmented into:
- Instruments
- Detection Kits
Application is further segmented into:
- Regenerative medicine & therapy development
- Drug discovery and development
- Clinical research
End-user segment include:
- Research institutes
- Industry research
On the basis of type, the global market of stem cell assay is segmented into viability/cytotoxicity, cell identification, isolation & purification, proliferation, function differentiation, and apoptosis. The viability/cytotoxicity segment is anticipated to account for the major segment of the global market in 2016. Pharmaceutical industries have increasingly concentrated on drug screening that has resulted in the increasing demand for stem cell assays.
On the basis of kits, the global market of stem cell assay is segmented into human embryonic stem cell kits and adult stem cell kits. The adult stem cell kits are again segmented into mesenchymal stem cell kit, hematopoietic stem cell kits, induced pluripotent stem cells kits (IPSCs), and neuronal stem cell kits and umbilical cord stem cell kits. Scientific interest in adult stem cells is generated due to their ability to self-renew or divide indefinitely, and can generate all the cell type of the organs from that they originate, potentially regenerating the full organ from a some cells. Not like embryonic stem cells, the usage of human adult stem cell in research and therapy is not measured to be controversial, as they are results from adult tissue sample instead of human embryos designated for scientific research. They have chiefly been studied in human and model organisms like as mice and rats. The adult stem cell kits segment is anticipated to witness the maximum CAGR during the forecast period 2016 to 2023. The huge growth in this segment can be mainly attributed to the efficiency of this type of kit in terms of stem cell analysis.
On the basis of application, the global market is classified into drug discovery and development, regenerative medicine & therapy development, and clinical research. The regenerative medicine & therapy development is again segmented into orthopedic& musculoskeletal spine, dermatology, diabetes central nervous system, cardiovascular, oncology and others. The regenerative medicine & therapy development segment is expected to show the highest growth rate during the coming period. The growth is associated with the rising in incidences of chronic diseases which again leads to the rising demand for regenerative medicines. On the basis of instruments, the global market of stem cell assay is categorized into micro electrode arrays, cell imaging systems, automated cell counter and flow cytometer. The flow cytometer segment is projected to witness the highest CAGR during the coming period. The huge growth in this segment is connected with the growing demand for cell analysis in industrial research.
Based on the end-users, the global market of stem cell assay is segmented into industry research and research institutes. The industry research segment is estimated to account for the major share of the global market in the near future. The increasing adoption of stem cell assay for drug testing & screening is one of the key reasons driving the industry research market.
The revenue for the above application and end-user segments are specific to the stem cell assay market. However, the total revenue of these application and end-user in general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing up product and kits segments.
The global stem cell assay market report is geographically segmented into:
- North America (U.S. & Canada)
- Asia Pacific (China, India, Japan, RoAPAC)
- Europe (UK, France, Germany, RoE)
- Rest of World
The market of stem cell assay is dominated by North America, which is followed by Europe. Growth in the North American is chiefly driven by the increasing patient pool and rising incidence and prevalence of chronic diseases. The huge growth in this segment is centred in the Middle East, Latin America, and Africa due to the rising adoption of stem cell based therapies.
The key players in the global market of stem cell assay are Promega Corporation (U.S.), GE Healthcare (U.K.), Thermo Fisher Scientific Inc. (U.S.), Cell Biolabs, Inc. (U.S.), Merck KGaA (Germany), Hemogenix Inc. (U.S.), Bio-Rad Laboratories, Inc (U.S.), STEMCELL Technologies Inc. (CA), Cellular Dynamics International, Inc. (U.S.) and Bio-Techne Corporation (U.S.). Major strategies adopted by these key players are collaboration, product launch, partnership and acquisition and merger etc. GE Healthcare is acquired Biosafe Group SA, a leading supplier of integrated cell bioprocessing systems for the faster growing cell therapy and regenerative medicine industry for a hidden sum. The acquisition of Biosafe expands GE Healthcare’s end-to-end ecosystem of solutions, products, and services for our cell therapy customer, and expand the GE’s technology reach to many new cell and therapy types.
The major market players of the global stem cell assay market are:
- GE HEALTHCARE
- PROMEGA CORPORATION
- THERMO FISHER SCIENTIFIC PVT. LTD
- STEM CELL TECHNOLOGIES.
- CELLULAR DYNAMICS INTERNATIONAL
- OTHERS
These companies use various strategies such as mergers & acquisitions, collaboration, partnership and product launch. Whereas, merger & acquisition is the key strategy adopted by the companies in the stem cell assay market.
For Example: GE Healthcare acquired Biosafe Group SA, a leading supplier of integrated cell bio processing systems on July 13, 2016. The acquisition of Biosafe expanded GE Healthcare’s end-to-end ecosystem of solutions, products, and services for our cell therapy customer, and expand the GE’s technology reach to many new cell and therapy types.
The report covers detailed analysis of companies which comprises of overview, SCOT analysis, product portfolio, strategic initiative, strategic analysis, competitive landscape and market share analysis in stem cell assay market.
Key reasons to buy the report:
- The report includes market estimation, forecast and analysis for the year 2016-2023
- Report includes detailed analysis of different segments such as application and end-user of global stem cell assay market.
- Identify and understand the strengths, opportunities, challenges and threats of the stem cell assay market.
- Covers details analysis of Porters 5 force model and other strategic models and also covers revenues, market share analysis, and competitive landscape analysis of major players of stem cell assay segment market.
- Detailed analysis of various regulatory policies which affect the global stem cell assay market.
How we are different from others:
At Occams we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global stem cell assay market offers detailed analysis of strategic models such as investment vs. adoption model, see saw analysis and others strategic models. Also, the report contains the detailed analysis of application, adoption scenario and decision support for each segment. The report discusses competitive landscape of the stem cell assay market, with giving extensive SCOT analysisof key companies.
Key findings of the global stem cell assay market:
- North America held highest revenue share in 2016.
- Adult stem cell kit is expected to have high growth rate during the forecast period 2016-2023. Due to effectiveness of adult stem cell in cell analysis.
- Regenerative medicine and therapy segment is the major segment of application.
- Acquisition is the key strategy adopted by players of stem cell assay market.
